3 High Growth Companies With Significant Insider Ownership On The TSX

Over the last 7 days, the Canadian market has dropped 2.8%, driven by pullbacks in the Financials and Materials sectors of 3.1% and 6.7%, respectively. Despite this short-term decline, the market is up 8.1% over the past year with earnings forecast to grow by 15% annually. In such a fluctuating environment, identifying growth companies with significant insider ownership can provide an added layer of confidence for investors seeking stability and potential upside in their portfolios.

Top 10 Growth Companies With High Insider Ownership In Canada

Name	Insider Ownership	Earnings Growth
Vox Royalty (TSX:VOXR)	12.6%	58.4%
goeasy (TSX:GSY)	21.5%	16.3%
Payfare (TSX:PAY)	14.8%	39.7%
Medicenna Therapeutics (TSX:MDNA)	15.4%	57.2%
Ivanhoe Mines (TSX:IVN)	12.3%	40.9%
Allied Gold (TSX:AAUC)	22.5%	58.0%
Alpha Cognition (CNSX:ACOG)	17.9%	66.5%
Aya Gold & Silver (TSX:AYA)	10.3%	68.5%
Artemis Gold (TSXV:ARTG)	29.8%	43.6%
Magna Mining (TSXV:NICU)	10.6%	94.7%

Click here to see the full list of 35 stocks from our Fast Growing TSX Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Knight Therapeutics (TSX:GUD)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Knight Therapeutics Inc. develops, manufactures, acquires, licenses, markets, and distributes pharmaceutical and consumer health products as well as medical devices worldwide with a market cap of CA$561.35 million.

Operations: The company's revenue segment includes CA$332.21 million from pharmaceuticals.

Insider Ownership: 22.3%

Knight Therapeutics, a growth company with high insider ownership, recently reported Q2 2024 earnings with sales of C$95.57 million, up from C$89.91 million a year ago, but incurred a net loss of C$1.94 million compared to net income of C$1.84 million previously. The company raised its 2024 revenue guidance to between $355-$365 million and announced a share repurchase program for up to 5.24% of its outstanding shares, indicating confidence in long-term growth despite short-term losses.

• Get an in-depth perspective on Knight Therapeutics' performance by reading our analyst estimates report here.
• According our valuation report, there's an indication that Knight Therapeutics' share price might be on the cheaper side.

Savaria (TSX:SIS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Savaria Corporation offers accessibility solutions for the elderly and physically challenged individuals across Canada, the United States, Europe, and internationally, with a market cap of CA$1.36 billion.

Operations: Savaria's revenue segments include CA$183.82 million from Patient Care and CA$650.96 million from Segment Adjustment.

Insider Ownership: 19.6%

Savaria's earnings are forecast to grow 24.87% annually, outpacing the Canadian market's 14.7%. Despite trading at 66.1% below its estimated fair value, Savaria has seen no substantial insider buying recently and experienced shareholder dilution over the past year. Q2 2024 results showed sales of C$221.34 million and net income of C$10.96 million, both higher than a year ago, reflecting solid growth potential but tempered by recent insider selling activity.

• Delve into the full analysis future growth report here for a deeper understanding of Savaria.
• In light of our recent valuation report, it seems possible that Savaria is trading beyond its estimated value.

Vitalhub (TSX:VHI)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vitalhub Corp. offers technology solutions for health and human service providers across multiple countries, including Canada, the United States, and the United Kingdom, with a market cap of CA$417.50 million.

Operations: Vitalhub Corp.'s revenue from healthcare software solutions amounts to CA$55.17 million.

Insider Ownership: 15.1%

Vitalhub's earnings are expected to grow significantly at 39.6% annually, surpassing the Canadian market's 14.7%. Despite trading at 65.9% below its estimated fair value, recent results showed mixed performance with Q2 revenue rising to C$16.24 million but a net loss of C$0.34 million compared to net income last year. The company has not seen substantial insider trading recently and experienced shareholder dilution over the past year.

• Navigate through the intricacies of Vitalhub with our comprehensive analyst estimates report here.
• The analysis detailed in our Vitalhub valuation report hints at an inflated share price compared to its estimated value.

Summing It All Up

• Access the full spectrum of 35 Fast Growing TSX Companies With High Insider Ownership by clicking on this link.
• Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com